ICMR programme on Antibiotic Stewardship, Prevention of Infection & Control (ASPIC).
Antimicrobial resistance and hospital infections have increased alarmingly in India. Antibiotic stewardship and hospital infection control are two broad strategies which have been employed globally to contain the problems of resistance and infections. For this to succeed, it is important to bring on board the various stakeholders in hospitals, especially the clinical pharmacologists. The discipline of clinical pharmacology needs to be involved in themes such as antimicrobial resistance and hospital infection which truly impact patient care. Clinical pharmacologists need to collaborate with faculty in other disciplines such as microbiology to achieve good outcomes for optimal patient care in the hospital setting. The ASPIC programme was initiated by the Indian Council of Medical Research (ICMR) in response to the above need and was designed to bring together faculty from clinical pharmacology, microbiology and other disciplines to collaborate on initiating and improving antibiotic stewardship and concurrently curbing hospital infections through feasible infection control practices. This programme involves the participation of 20 centres per year throughout the country which come together for a training workshop. Topics pertaining to the above areas are discussed in addition to planning a project which helps to improve antibiotic stewardship and infection control practices in the various centres. It is hoped that this programme would empower hospitals and institutions throughout the country to improve antibiotic stewardship and infection control and ultimately contain antimicrobial resistance.
Sujith J
SJ
Chandy
Joy Sarojini
JS
Michael
Balaji
B
Veeraraghavan
O C
OC
Abraham
Sagar S
SS
Bachhav
Office of National Chair in Clinical Pharmacology, Indian Council of Medical Research, Mumbai, India.
Nilima A
NA
Kshirsagar
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D035843:Biomedical Research; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D004352:Drug Resistance, Microbial / Q000187:drug effects / Q000235:genetics; D004363:Drug Utilization; D006761:Hospitals; D006801:Humans; D007194:India; D017053:Infection Control / Q000379:methods
D000900:Anti-Bacterial Agents